Allyson Pollock

Title: Professor
FFPH, FRCGP
Professor of Public Health Research and Policy; director, Global Public Health Unit

Prof Allyson Pollock and her colleagues undertake research and teaching intended to assist realisation of the principles of social justice and public health, with a particular emphasis on heath systems research, trade, and pharmaceuticals. A strong emphasis is on developing critical analysis through education and research and through translating research findings into policy at the national and international level. The work is interdisciplinary, including epidemiology, law, statistics, economics, accounting, sociology, and anthropology.

Universal access to health care is the primary focus and in particular the means by which local and national systems redistribute resources across society by sharing the risks and costs of ill-health. The work includes the study of public private partnerships in health and long term care, pharmaceuticals, and medical research, and how public health interfaces with trade law and intellectual property agreements.

Local and global issues converge around, for instance, the social and economic aspects of clinical trials, how medicines are accessed, the estimation of the global burden of disease, and evidence underpinning access to medicines policies; the setting of health care priorities through the creation and use of clinical evidence; and the export of managed health care systems.

Personal website: http://www.allysonpollock.com/

Bio

Allyson Pollock is Professor of Public Health Research & Policy. She was director of the Centre for International Public Health Policy at the University of Edinburgh and before that head of the Public Health Policy Unit at UCL and director of research & development at UCL Hospitals NHS Trust. She trained in medicine in Scotland and became a consultant in public health in 1986.

Her research interests include globalisation, privatisation, marketisation and PFI / PPPs, pharmaceuticals and clinical trials and child injuries. She is the author of NHS plc, The New NHS: a guide, and Tackling rugby: what every parent should know about injuries

Research

Public health research; globalisation and public health; intellectual property, pharmaceuticals, and medical research; public private partnerships; childhood injury

Publications

 
Atukunda, EC,Brhlikova P, Agaba AG, Pollock AMCivil society organizations and medicines policy change: a case study of registration, procurement, distribution and use of misoprostol in Uganda. Social Science & Medicine. 2015;130:242–9.
Brhlikova P, Harper I, Subedi M, Bhattarai S, Rawal N, Pollock AM. Aid conditionalities, international Good Manufacturing Practice standards and local production rights: a case study of local production in Nepal. Globalization and Health 11(25).
Crocker-Buque T, Pollock AM. Appraising the quality of sub-Saharan African cancer registration systems that contributed to GLOBOCAN 2008: a review of the literature and critical appraisal. JRSM. 2015;108(2):57–67.
Evans V,Pollock AM. The proliferation of irrational metformin fixed-dose combinations in India. The Lancet Diabetes and Endocrinology. 2015;3(2):98–100.
Freitag A, Kirkwood G, Pollock AM. Rugby injury surveillance and prevention programmes: are they effective? BMJ. 2015;350:h1587.
Freitag A, Kirkwood G, Scharer S, Ofori-Asenso R, Pollock AMSystematic review of rugby injuries in children and adolescents under 21 years. 
Br J Sports Med 2015;49:511–9.
Harrington C, Armstrong H, Halladay M, Havig AK, Jacobsen FF, MacDonald M, et al. Comparison of nursing home financial transparency and accountability in four locations. Ageing Int. 2015 Nov 19;1–23.
Kirkwood G, Parekh N, Ofori-Asenso R,Pollock AM. Concussion in youth rugby union and rugby league: a systematic review. Br J Sports Med 2015;49:506–10.
Leng H, Sanders D, Pollock AM. Pro-generics policies and the backlog in medicines registration in South Africa: implications for access to essential and affordable medicines. GaBi Journal. 2015;4(2)
Maigetter K, Pollock AM, Kadam A, Ward K, Weiss MG. Pharmacovigilance in India, Uganda and South Africa with reference to WHO’s minimum requirements. Int J Health Policy Manag. 2015;4;5:295-305.
McGettigan P, Roderick P, Mahajan R, Kadam A, Pollock AM. Use of fixed dose combination (FDC) drugs in India: central regulatory approval and sales of FDCs containing non-steroidal anti-inflammatory drugs (NSAIDs), metformin, or psychotropic drugs. PLoS Med. 2015;12(5):e1001826.
Millard C, Brhlikova P, Pollock AM. Social networks and health policy: the case of misoprostol and the WHO model essential medicine list. Social Science & Medicine. 2015;132:190–6.
Pollock AM. Morality and values in support of universal healthcare must be enshrined in law; comment on ‘Morality and markets in the NHS’. Int J Health Policy Manag. 2015;4(6):399–402.
Pollock AM, Roderick P. Why the Queen’s Speech on 19 May should include a bill to reinstate the NHS in England. BMJ. 2015;350:h2257.
Smith D, Kirkwood G, Pott J, Kourita L, Jessop V, Pollock AM. Childhood injury in Tower Hamlets: audit of children presenting with injury to an inner city A and E department in London. Injury, Int J Care Injured. 2015.
Steele S, Freitag A, McGettigan P, Giovannoni G, Pollock AM. A guide to private prescribing. Prescriber. 2015 Mar 19;19–23. 
 
Birabwa C, Murison J, Evans V, Obua C, Agaba A, Waako P, et al. The availability of six tracer medicines in private medicine outlets in Uganda. Journal of Pharmaceutical Policy and Practice. 2014;7(18).
Kirkwood G, Pollock AM, Howie C, Wild S. NHS Scotland reduces the postcode lottery for hip arthroplasty following the introduction of waiting time initiatives. JRSM 2014;107(6):237-45.
Kirkwood G, Hughes T, Pollock AM. Injury surveillance in Europe and the UK. BMJ 2014;349:g5337
Millard C, Pollock AM, Brhlikova P. Evidence versus influence in the WHO procedure for approving essential medicines: misoprostol for maternal health. BMJ. 2014;349:g4823.
Pollock AM. Tackling rugby: what every parent should know about injuries. London: Verso; 2014Roderick P, Mahajan R, McGettigan P, Pollock AM. India should introduce a new Drugs Act. The Lancet. 2014;383(9913):203–6.
Pollock AM, Roderick P. Trust in the time of markets: protecting patient information. The Lancet 2014;383(9928):1523–1524.Roderick P, Mahajan R, McGettigan P, Pollock AM. India should introduce a new Drugs Act. The Lancet 2014;383(9913):203-206.
Roderick P, Pollock AM. A wolf in sheep's clothing: how Monitor's is using licensing powers to reduce hospital and community services in England under the guise of continuity, BMJ 2014;349:g5603.
Steele S, Stuckler D, McKee M, Pollock AM. The Immigration Bill: extending charging regimes and scapegoating the vulnerable will pose risks to public health. JRSM 2014;107(4):132–133.Ward K, Sanders D, Leng H, Pollock AM. Assessing equity in the geographical distribution of community pharmacies in South Africa in preparation for a national health insurance scheme. Bulletin of the WHO 2014;92:482-489.
 

Atukunda EC, Brhlikova P, Agaba AG, Pollock AM. Registration, procurement, distribution, and use of misoprostol in Uganda: an interview-based observational study. The Lancet 382 (Suppl 1) 2013;10
Pollock AM, Price D. Loss of population data sources when health systems are not responsible for geographically defined populations: implications of the Health and Social Care Act of 2012 in England. Evidence-Based Medicine Published Online First: 3 May 2013.
Pollock AM, Price D. Mid Staffordshire should lead to a fundamental rethink of government policy. BMJ 2013;346:f2190.
Pollock AM, Price D, Kondilis E, Freitag A, Harding-Edgar L. Planning for closure: the role of special administrators in reducing NHS hospital services in England. BMJ. 2013 Dec 13;347(dec12 5):f7322–f7322.

Chu C, Brhlikova P, Pollock AM. Rethinking WHO guidance: review of evidence for misoprostol use in the prevention of postpartum haemorrhage. J R Soc Med 2012;105:336-347.
Mattheij I, Pollock AM. Do cervical cancer data justify HPV vaccination in India? Epidemiological data sources and comprehensiveness. J R Soc Med 2012;105(6):250-262.
Pollock AM, Brhlikova P, McGettigan P. Reviewer's commentary on 'Should oral misoprostol be used to prevent postpartum haemorrhage in home-birth settings' in low-resource countries? A systematic review of the evidence' [Hundley et al 2012]. BJOG 2012;123(3):277-87.
Pollock AM, Macfarlane A, Godden S. Dismantling the signposts to public health? NHS data under the Health and Social Care Act 2012 BMJ 2012 ; 344 doi: 10.1136/bmj.e2364.
Pollock AM, Price D. PFI hospitals bear the cost of Libor manipulation. BMJ 2012;345:e5095
Pollock AM, Price D, Roderick P. Health and Social Care Bill 2011: a legal basis for charging and providing fewer health services to people in England. BMJ 2012;344:e1729.
Pollock AM, Price D, Roderick P, Treuherz T. A flawed Bill with a hidden purpose. The Lancet 2012;379(9820):999.
Pollock AM, Price D, Roderick P, Treuherz T, McCoy D, McKee M, Reynolds L. How the health and social care bill 2011 would end entitlement to comprehensive health care in England. The Lancet 2012;379:387-389.
Roderick P, Pollock AM. India's patent laws under pressure. The Lancet 2012;380(9846):e2-4.

Brhlikova P, Pollock AM, Manners R. Global Burden of Disease estimates of depression - how reliable is the epidemiological evidence? J R Soc Med 2011;104:25–35.
Godden S, Hilton S, Pollock AM. Monitoring access to out-of-hours care services in Scotland - a review. J R Soc Med 2011;104:162-172
Parekh N, Hodges S, Pollock AM, Kirkwood G. Communicating the risk of injury in schoolboy rugby: using Poisson probability as an alternative presentation of the epidemiology. Br J Sports Med 2012;46:611-3.
Pollock AM, Macfarlane A, Kirkwood G, Majeed A, Greener I, Morelli C, Mellett H, Godden S, Price D, Brhlikova P. No evidence that patient choice in the NHS saves lives. The Lancet online first 10 Oct 2011
Pollock AM, Price D. The break up of the English NHS: the new market bureaucracy needs information systems based on members and not geographic populations. Michael Quarterly 2011;8:460–75.
Pollock AM, Price D. The final frontier: The UK's new coalition government turns the English National Health Service over to the global health care market. Health Sociology Review 2011 20(3):294–305.
Pollock AM, Price D. How the secretary of state for health proposes to abolish the NHS in England. BMJ 2011;342:d1695.
Price D, Pollock AM, Brhlikova P. Classification problems and the dividing line between government and the market: an examination of NHS foundation trust classification in the UK. Annals of Public and Cooperative Economics 2011;82:455–473.
Price D, Pollock AM, Liebe M. Private finance initiatives during NHS austerity. BMJ 2011;342 doi:10.1136/bmj.d324.

View all Allyson Pollock's Research Publications at: http://www.researchpublications.qmul.ac.uk


 

Teaching

Topics for PhD supervision

globalisation and public health
pharmaceuticals and medical research
public private partnerships
long term care


Further information

  • Member, Council of the British Medical Association, 2014-18
  • Member, international committee of the British Medical Association, 2014-18
  • Member, public health committee of the British Medical Association, 2014-18
  • Member, national advisory panel, Centre for Labour and Social Studies (CLASS)
  • Member of the Bevan Commission, which provides independent, expert advice to the Welsh Minister for Health and Social Services “to help ensure that changes in NHS structures set Wales on the path to a world class healthcare system” 2008-14

 

Contact

Centre for Primary Care and Public Health
Blizard Institute
Barts and The London School of Medicine and Dentistry
Yvonne Carter Building
58 Turner Street
London
E1 2AB

020 7882 5637 / 020 7882 7212

This email address is being protected from spambots. You need JavaScript enabled to view it. 

020 7882 5637
This email address is being protected from spambots. You need JavaScript enabled to view it.